Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Ryan Specialty Holdings
RYAN
$4.67B
| $5.38M | ﹤0.01% |
104,138
-31,307
| -23% | -$1.72M |
2022 Q1
15 quarters
|
|
2152
BOK Financial
BOKF
$7.73B
| $5.37M | ﹤0.01% |
45,367
+42,579
| +1,527% | +$4.77M |
2015 Q2
42 quarters
|
|
2153
Constellium
CSTM
$3.38B
| $5.37M | ﹤0.01% |
285,046
+9,780
| +4% | +$162K |
2022 Q1
15 quarters
|
|
2154
CALL
General Motors
GM
$70.1B
| $5.36M | ﹤0.01% |
65,900
-186,900
| -74% | -$13.2M |
2022 Q4
12 quarters
|
|
|
SNDK
2155
PUT
Sandisk
SNDK
$252B
| $5.36M | ﹤0.01% |
22,572
| – | – |
2025 Q1
3 quarters
|
|
2156
PUT
Under Armour
UAA
$1.99B
| $5.34M | ﹤0.01% |
1,075,000
+850,000
| +378% | +$3.93M |
2024 Q3
5 quarters
|
|
2157
Otter Tail
OTTR
$3.74B
| $5.33M | ﹤0.01% |
65,900
+2,659
| +4% | +$215K |
2016 Q1
39 quarters
|
|
2158
GameStop
GME
$12.8B
| $5.32M | ﹤0.01% |
264,754
-108,346
| -29% | -$2.43M |
2013 Q2
50 quarters
|
|
2159
Provident Financial Services
PFS
$2.92B
| $5.31M | ﹤0.01% |
269,079
+45,552
| +20% | +$881K |
2013 Q2
50 quarters
|
|
2160
California Water Service
CWT
$2.82B
| $5.31M | ﹤0.01% |
122,521
+12,636
| +11% | +$576K |
2013 Q2
50 quarters
|
|
2161
Dorman Products
DORM
$3.67B
| $5.31M | ﹤0.01% |
43,064
+3,504
| +9% | +$473K |
2016 Q1
39 quarters
|
|
|
OSG
2162
Octave Specialty Group
OSG
$211M
| $5.29M | ﹤0.01% |
680,441
+10,928
| +2% | +$93.4K |
2013 Q2
50 quarters
|
|
2163
Immunome
IMNM
$2.4B
| $5.29M | ﹤0.01% |
246,065
+37,552
| +18% | +$659K |
2023 Q4
8 quarters
|
|
2164
AMC Global Media
AMCX
$463M
| $5.26M | ﹤0.01% |
552,709
+2,404
| +0.4% | +$20.3K |
2013 Q2
50 quarters
|
|
2165
FB Financial Corp
FBK
$2.64B
| $5.26M | ﹤0.01% |
94,255
+22,931
| +32% | +$1.28M |
2017 Q1
35 quarters
|
|
|
ORKA
2166
Oruka Therapeutics
ORKA
$5.56B
| $5.25M | ﹤0.01% |
173,329
+77,999
| +82% | +$2.17M |
2024 Q4
4 quarters
|
|
2167
Gates Industrial Corp
GTES
$7.04B
| $5.25M | ﹤0.01% |
244,552
-55,001
| -18% | -$1.27M |
2018 Q1
31 quarters
|
|
|
MH
2168
McGraw Hill
MH
$2.48B
| $5.24M | ﹤0.01% |
317,545
+256,592
| +421% | +$3.72M |
2025 Q3
1 quarter
|
|
2169
Myers Industries
MYE
$1.18B
| $5.24M | ﹤0.01% |
279,858
-23,292
| -8% | -$413K |
2016 Q2
38 quarters
|
|
2170
Healthcare Realty
HR
$5.97B
| $5.24M | ﹤0.01% |
308,948
-443,479
| -59% | -$7.89M |
2013 Q2
50 quarters
|
|
2171
CALL
Samsara
IOT
$25B
| $5.24M | ﹤0.01% |
147,700
-26,300
| -15% | -$1.02M |
2025 Q3
1 quarter
|
|
2172
Kodiak Gas Services
KGS
$5.5B
| $5.22M | ﹤0.01% |
139,682
+23,330
| +20% | +$825K |
2023 Q3
9 quarters
|
|
2173
Seacoast Banking Corp of Florida
SBCF
$3.14B
| $5.22M | ﹤0.01% |
166,050
+39,356
| +31% | +$1.23M |
2016 Q3
37 quarters
|
|
2174
Huron Consulting
HURN
$2.6B
| $5.21M | ﹤0.01% |
30,142
+4,369
| +17% | +$715K |
2013 Q2
50 quarters
|
|
2175
Calix
CALX
$2.2B
| $5.2M | ﹤0.01% |
98,322
+9,055
| +10% | +$527K |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.